跳至主要内容
临床试验/NCT00148551
NCT00148551Unknown2 期

Triamcinolone Acetonide as an Adjunctive Treatment to Verteporfin Therapy in Neovascular Age-Related Macular Degeneration: Randomized Placebo-Controlled Clinical Trial.

Canadian Retinal Trials Group1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2004年1月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
发起方
入组人数
120
试验地点
1
主要终点
Changes in visual acuity from baseline.

研究概览

简要总结

A 24 - month Study looking at the the changes in visual acuity of patients receiving PDT therapy in conjunction with intravitreal triamcinolone.

详细描述

This study will evaluate the effect of Triamcinolone Acetonide in conjunction with photodynamic therapy for the treatment of sub-foveal choroidal neovascular membranes secondary to age-related macular degeneration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals with predominantly classic, subfoveal CNV secondary to AMD.
  • No previous PDT Treatment in study eye.

排除标准

  • CNV from conditions, other than AMD.
  • Other disease that could be responsible for decreased vision.

结局指标

主要结局

Changes in visual acuity from baseline.

次要结局

  • Change in lesion characteristics from baseline.

研究者

发起方
Canadian Retinal Trials Group
申办方类型
Other

研究点 (1)

Loading locations...

相似试验